@article{2cfb328224a643eea3e6ab903cb544a2,
title = "The authors reply:: KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease",
abstract = "The Kidney Disease: Improving Global Outcomes (KDIGO) 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease Work Group1 agrees with the statement by Fonseca et al.2 that hemoglobin A1c (HbA1c) may be unreliable in advanced chronic kidney disease (CKD). In addition to hyperglycemia, patients with advanced CKD are at an increased risk of hypoglycemia, and measures that more precisely reflect blood glucose levels are needed. ",
keywords = "glycemic control, chronic kidney disease, Hemoglobin A1c, Albumin, Prognostic studies",
author = "Caramori, {M. Luiza} and Tuttle, {Katherine R.} and Nikhil Tandon and Tunnicliffe, {David J.} and {de Boer}, {Ian H.} and Peter Rossing and {Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group} and Chan, {Juliana C.N.} and Heerspink, {Hiddo J.L.} and Clint Hurst and Kamlesh Khunti and Adrian Liew and Michos, {Erin D.} and Navaneethan, {Sankar D.} and Olowu, {Wasiu A.} and Tami Sadusky and Christoph Wanner and Wilkens, {Katy G.} and Sophia Zoungas and Lyubov Lytvyn and Craig, {Jonathan C.} and Martin Howell and Marcello Tonelli and Michael Cheung and Amy Earley",
year = "2022",
month = feb,
doi = "10.1016/j.kint.2021.11.019",
language = "English",
volume = "101",
pages = "420--421",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Kidney International",
number = "2",
}
